Bli medlem
Bli medlem

Du är här


BGBIO: BerGenBio ASA: Share capital increase

Bergen, Norway, 11 May 2020 - Reference is made to the stock exchange notice
published by BerGenBio ASA (the "Company") (OSE: BGBIO) on 4 May 2020 where the
Company announced that the board of directors of the Company had resolved to
increase the Company's share capital in connection with the private placement
and share option program. A total of 13,325,000 shares were issued in the
private placement at a subscription price of NOK 37.50 per share and a total of
102,500 share options where exercised and new shares issued at an average
subscription price at NOK 11.15 per share.

The share capital increase has been duly registered in the Norwegian Register of
Business Enterprises. Following such registration, the Company's share capital
is NOK 8,672,580.50 divided into 86,725,805 shares, each with a nominal value of
NOK 0.10.



Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Rune Skeie

CFO, BerGenBio ASA 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the
expectations expressed or implied in this announcement by such forward-looking

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

Source Url:

Författare OSE News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.